TrialArteriosclerosis, thrombosis, and vascular biology2016

Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.

Gissette Reyes-Soffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.